Royal Bank of Canada
PAND

Royal Bank of Canada’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Royal Bank of Canada’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,308
Closed -$79K – 8003
2021
Q1 		$79K Buy
1,308
+968
+285% +$35K ﹤0.01% 5615
2020
Q4 		$5K Buy
+340
New +$4.73K ﹤0.01% 6705

Royal Bank of Canada's PAND Position: Q2 2021 in Review

Royal Bank of Canada sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,308 shares — an estimated $79K sold.

Royal Bank of Canada first reported a position in PAND in Q4 2020 and held it in 2 quarters. The position peaked at $79K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Royal Bank of Canada reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 1,308 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $79K.
  • Royal Bank of Canada first reported a position in Pandion Therapeutics Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Royal Bank of Canada's Pandion Therapeutics Inc. Common Stock position peaked at $79K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.